ECO Animal Health Turns Profit Of £3 Mln In FY26; Receives First Order For ECOVAXXIN MS Vaccine

ECO Animal Health Group reported a higher full-year profit for the year ended March 31, 2026, driven by increased revenue, particularly in North America. The improvement versus last year suggests underlying demand strength. The article provides no specific figures or guidance changes in the excerpt.

Analysis

ECO Animal Health Group reported a higher full-year profit for the year ended March 31, 2026, driven by increased revenue, particularly in North America. The improvement versus last year suggests underlying demand strength. The article provides no specific figures or guidance changes in the excerpt.